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 23 
ABSTRACT 24 
Purpose: The purpose of this study was to examine the effects of acute caffeine intake 25 
on physical performance in three sets of unilateral knee extension with blood flow 26 
restriction. Methods: In a double-blind crossover design, 22 trained men ingested 6 27 
mg/kg of caffeine (CAF) or a placebo (PLA), 1 hour prior to performing  unilateral knee 28 
extension exercise with blood flow restriction until exhaustion (30% of 1RM). Results: 29 
There was a significant difference in the number of repetitions between the CAF and 30 
PLA conditions in the 1st set (28.3 ± 5.3 vs 23.7 ± 3.2; P=0.005), 2nd set (11.6 ± 3.1 vs 31 
8.9 ± 2.9; P=0.03), and total repetitions performed across the three sets (44.5 ± 9.4 vs 32 
35.0 ± 6.6; P=0.001). Blood lactate was also significantly different (P=0.03) after 33 
exercise between the CAF (7.8 ± 1.1 mmol.L-1) and PLA (6.0 ± 0.9 mmol.L-1). In regard 34 
to pain perception, there was a difference between the CAF and PLA in the 2nd (6.9 ± 35 
1.5 vs 8.4 ± 1.4; P=0.04) and 3rd sets (8.7 ± 0.4 vs 9.5 ± 0.6; P=0.01). No differences 36 
were found for perceived effort. Conclusion: Acute caffeine intake increases 37 
performance, blood lactate concentration and reduces perception of pain in unilateral 38 
knee extension exercise with blood flow restriction. 39 
 40 
 41 
42 
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INTRODUCTION 43 
Resistance training of moderate/high load (> 60% of 1 maximal repetition - 44 
RM) is considered an integral part of any physical conditioning program to increase 45 
muscle strength or muscle mass for health in adults1. However, in recent years 46 
resistance training with low loads (<30% 1RM), performed with blood flow restriction 47 
(BFR), has been suggested as being similarly effective as moderate/high-load 48 
resistance training in increasing strength and muscle mass2. Although the 49 
physiological mechanisms regarding the improvement of strength and muscle mass 50 
after a low-load resistance training program with BFR are still unclear3,4, this training 51 
model has application both for healthy, non-trained subjects at different ages5,6 and 52 
athletes4. In this context, while resistance training with BFR is not significantly better 53 
than traditional moderate/high-load resistance training to improve strength and/or 54 
muscle mass, it can be added into the training routine as a variation of exercises and 55 
may provide an alternative exercise mode that some individuals find more appealing 56 
than traditional resistance training. 57 
In the context of resistance training to increase physical performance, in 58 
addition to training per se, it is common for athletes and recreational exercisers to use 59 
ergogenic aids7 as a means to increase or accelerate changes in physical 60 
performance. Caffeine, for example, is one of the most widely used ergogenic aids, 61 
often employed to increase performance in exercises involving muscular strength8, 62 
especially when performing several repetitions until exhaustion9. The mechanism of 63 
action for caffeine has been explained by the high affinity of caffeine with adenosine 64 
receptors, inhibiting the action of this substance10 and, consequently, reducing the 65 
perception of effort and pain11. Likewise, caffeine can promote greater performance in 66 
the propagation of signals between the brain and neuromuscular junction12, acting 67 
4 
 
peripherally on the ryanodine channels in the release of calcium, optimizing the 68 
process of excitation-contraction of the skeletal musculature13. In the context of the 69 
BFR-resistance exercise model, sustained blood flow reduction to the muscle during 70 
exercise may reduce intramuscular calcium influx14, which could theoretically limit the 71 
effect of caffeine on the excitation-contraction coupling process in skeletal muscles. 72 
However, the possible ergogenic effects of caffeine have not yet been investigated in 73 
low intensity resistance exercise with BFR.  Given there is potential for both caffeine 74 
ingestion and BFR to act independently and possibly synergistically, it is important to 75 
examine if this is the case. No study to date has examined this issue. 76 
In this sense, the purpose of this study was to examine the effects of acute 77 
caffeine intake on physical performance in three sets of unilateral knee extension with 78 
BFR to failure. Additionally, rating of perceived exertion, perceived pain and blood 79 
lactate concentration were analyzed. 80 
 81 
MATERIALS AND METHODS 82 
Subjects 83 
Sample size calculation was performed considering a difference between 84 
two means of three repetitions, an expected standard deviation of 2, statistical power 85 
of 80%, and level of significance lower than 0.05 in a pilot sample of this study. Thus, 86 
the minimum sample required was 16 subjects. Consequently, the sample in the 87 
current study included 22 trained men (Table 1) to account for potential drop out during 88 
the experimental procedures. The inclusion criteria to take part were: non-smokers, 89 
non-users of dietary supplements, non-users of anabolic steroids, the absence of 90 
muscular or metabolic problems, body mass index below 30 kg.m2, trained in 91 
bodybuilding for at least 12 months (but without experience with BFR exercises), and 92 
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non-habitual caffeine users. Individuals were instructed not to engage in vigorous 93 
exercise or consume alcoholic beverages for 72 h prior to each testing session until 94 
the end of the experiment. All participants were informed about the study procedures 95 
and possible effects of caffeine intake and provided informed consent to participate. 96 
The study was approved by institutional ethics   of the State University of Londrina 97 
(application number 1.141.230/2015). 98 
 99 
Experimental design 100 
The study employed a repeated-measures, within-subjects design and was 101 
conducted during four non-consecutive days with intervals of between 48-72 h. 102 
Anthropometric measurements and 1RM testing was performed during the first visit. 103 
This was followed by familiarization with the scales that were used for subjective 104 
perception of effort (RPE)15 and pain (PP)16. On the second visit, the 1RM retest was 105 
performed. The remaining two visits were assigned to the experimental sessions 106 
administered using a randomized double-blind cross-over design. The subjects 107 
ingested either one capsule of caffeine (CAF) or a placebo (PLA) and, after 60 min, 108 
performed unilateral knee extension exercise with BFR (three sets to exhaustion, 1 109 
min recovery interval between sets, at an intensity of 30% 1RM). The BFR was 110 
maintained throughout the whole exercise bout (all sets and repetitions). Subjects were 111 
instructed and verbally encouraged to perform the maximum number of repetitions 112 
during each set. The repetitions were performed at a rate of 1.5 seconds (via digital 113 
metronome) for both concentric and eccentric contractions. The RPE and PP were 114 
applied after the end of each set. Blood lactate was collected after the end of the 115 
exercise. At the end of the experiment, the subjects were questioned as to whether 116 
they were able to distinguish between the two capsules to identify which was caffeine, 117 
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in order to determine efficacy of blinding and the individual perception of the effect of 118 
this substance. 119 
 120 
Maximum strength test 121 
The 1RM test and retest were performed within a 48-h interval using a 122 
unilateral extensor chair (the dominant leg) (TechnoGym®, Rome, Italy), was 123 
determined according to methods accomplished by Seo et al.17. A warm-up was 124 
performed with a set of 10 repetitions (~50% of predicted 1RM). Individuals were 125 
allowed up to five attempts to determine 1RM, with a recovery interval of 3-5 min. All 126 
subjects were instructed and verbally encouraged to perform one correct repetition. 127 
The load was considered maximal when the subjects performed only one complete 128 
repetition. The highest load obtained in either the test or retest 1RM trials was used in 129 
subsequent experimental trials. Test/retest reliability for the 1RM was performed and 130 
a high intraclass correlation coefficient (ICC) was found, R = 0.80. 131 
 132 
Caffeine or placebo intake 133 
For the experimental sessions, each subject ingested a capsule containing 134 
6 mg of caffeine per kilogram of body weight and a placebo capsule (maltodextrin) with 135 
200 ml of water administered in a randomized order. The habitual average caffeine 136 
intake of the participants was assessed through a questionnaire18 translated to 137 
Portuguese. All participants were considered low habitual caffeine users (80.1 ± 10.4 138 
mg.day-1). The same list was used to instruct the individuals not to consume the same 139 
substances for 48 h prior to testing.  140 
 141 
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Blood flow restriction 142 
To elicit BFR, a cuff 18 cm wide and 90 cm long was positioned on the 143 
proximal third of the thigh. A vascular Doppler (MARTEC DV600, São Paulo, Brazil) 144 
positioned on the posterior tibial artery was used to identify the sound of the passage 145 
of blood flow. From identification of the sound, the cuff was inflated until the sound was 146 
interrupted and, at that moment, the restriction value was recorded. Cuff pressure 147 
during the experimental session was maintained at 80% of the total blood flow 148 
restriction value and was released only after the end of the final set.   149 
 150 
Blood lactate collection  151 
Blood lactate concentration was obtained at the moment of rest during the 152 
first visit to the laboratory and at an interval of up to two minutes after the end of the 153 
final set of each experimental session. Prior to the blood sample collection, asepsis 154 
was performed with 70% alcohol on the digital pulp of the middle finger of the right 155 
hand. The puncture was performed using disposable lancets, the drop of blood (5µl) in 156 
suspension being applied to a specific area of the reactive strip and analyzed by means 157 
of a portable lactometer (AccutrendPlus, USA). 158 
 159 
Rating of perceived exertion and perceived pain 160 
To measure perceived exertion and perceived muscle pain, the OMNI 0-10 161 
rating of perceived exertion (RPE)15 and a perceived pain (PP)  visual analog scales16 162 
were used respectively. Familiarization with the scales was performed on the first day 163 
of the individuals' visit to the laboratory. Subsequently, during experimental trials, at 164 
the end of each set, the RPE and PP values were also collected.  165 
 166 
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Statistical analyses 167 
The Shapiro-Wilk test was used to verify the distribution of the data and the 168 
Levene’s test to verify the homogeneity of the variances. Considering the normal 169 
distribution of data, for the comparison of the number of repetitions, RPE, and PP a 170 
two-way ANOVA with repeated measures was used (caffeine/placebo x number of 171 
sets). The Student T-test for dependent samples was applied for the blood lactate 172 
analysis. Two-way ANOVA was used to compare the performance in the total number 173 
of repetitions, RPE, and PP, among those who identified correctly and those who made 174 
a mistake about the intake of the caffeine capsule. In all cases, the Tukey post-hoc 175 
test was used to identify significant results. Additionally, to determine the magnitude of 176 
the findings, Cohen’s d effect sizes (ES) were calculated for the differences between 177 
PLA and CAF, following the classification: small (0.20<ES<0.50), medium 178 
(0.50≤ES<0.80) or large (ES≥0.80). The level of significance adopted was P<0.05. The 179 
data were analyzed in Statistica 12.0 software (Statsoft, Tulsa, OK, USA).  180 
 181 
RESULTS 182 
Values are expressed as mean and standard deviation. 183 
Table 1 presents the general characteristics of the sample. Randomization 184 
showed that 10 subjects started with the CAF session and 12 subjects started with the 185 
PLA session. 186 
Table 2 shows the number of repetitions performed, RPE, and PP in the 187 
CAF and PLA conditions. For the number of repetitions performed, there was a 188 
significant interaction between CAF and PLA (F=18.45; P=0.02) with the Tukey post-189 
hoc test identifying a significant difference between the 1st and 2nd sets. The RPE 190 
analysis demonstrated no significant inter-group interaction. However, there was a 191 
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significant intra-group interaction in CAF (F=14.37; P=0.04) and PLA (F=16.65; 192 
P=0.03) conditions. RPE scores was significantly lower after the 1st set of CAF and 193 
PLA in relation to the other sets. For the PP analysis, there was significant interaction 194 
between CAF and PLA (F=23.78; P=0.01). The PP results demonstrated a progressive 195 
increase in the CAF condition from the 1st to 3rd sets. Conversely, in the PLA condition 196 
PP was only significantly different in the 1st set compared to the 2nd and 3rd sets. 197 
Furthermore, PP was significantly different between CAF and PLA in the 2nd and 3rd 198 
sets. 199 
The analysis of blood lactate, by Student’s T-test, showed no significant 200 
differences in resting values between the CAF (2.1 ± 0.3 mmol.L-1) and PLA (2.2 ± 0.2 201 
mmol.L-1; Cohen’s d ES = 0.39). After the end of the exercise, the values were 202 
significantly higher (P=0.002) than those observed at rest, and a significant difference 203 
(P=0.03) was observed between the CAF (7.8 ± 1.1 mmol.L-1) and PLA (6.0 ± 0.9 204 
mmol.L-1; Cohen’s d ES = 1.79) conditions. 205 
Table 3 shows the two-way ANOVA results for the total number of 206 
repetitions performed between subjects who correctly determined which condition was 207 
the caffeine condition and which the placebo. Nine subjects correctly identified the 208 
caffeine trial (true positive) and also performed more repetitions in this condition than 209 
after placebo intake. Similarly, those failing to correctly identify the caffeine trial also 210 
performed more repetitions than after taking the placebo. However, there was a 211 
significant difference in the number of repetitions completed after caffeine intake 212 
between those who identified and those who did not correctly identify caffeine (P 213 
<0.05). No differences were observed for RPE, PP, or lactate. 214 
Figure 1 presents the individual responses between CAF and PLA in terms 215 
of the total number of repetitions performed.  216 
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INSERT TABLE 1 218 
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INSERT FIGURE 1 221 
 222 
DISCUSSION 223 
The main findings of the present study were: 1) caffeine intake increased 224 
both the number of repetitions performed and capillary blood lactate whilst also 225 
reducing pain sensation in knee extension exercise with BFR; 2) subjects who 226 
accurately interpreted the caffeine trial as such performed more repetitions than those 227 
who did not perceive it accurately. In both cases, the Cohen’s d ES were large, ratifying 228 
the significant level identified. No study to date has examined the concurrent effects of 229 
caffeine ingestion and BFR on strength performance and few prior studies examining 230 
caffeine ingestion have also examined whether the participant’s perception of the 231 
substance ingested influences the response to the subsequent exercise protocol. As 232 
such the results of the present study are novel and extend the literature pertaining to 233 
effects of caffeine ingestion on exercise performance. 234 
One of the possible mechanisms of action of caffeine on physical 235 
performance occurs through the increase in the release of calcium in the sarcoplasmic 236 
reticulum, boosting the excitation-contraction process13. However, it is possible that 237 
calcium availability may be impaired under hypoxia conditions14. Thus, one of the 238 
potential explanations is that exercise with BFR reduced the availability of calcium and, 239 
consequently, compromised performance. In the present study, as performance did 240 
not decrease, on the contrary, it increased, we suggest two hypotheses to explain the 241 
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seemingly paradoxical findings we present. A BFR threshold of 80% BFR was 242 
employed in the present study as this threshold is commonly used in the literature19. 243 
As a consequence the experimental model did not apply vascular occlusion that 244 
interrupted 100% of the blood flow. This means, in the current study, there was no total 245 
hypoxia condition, despite less oxygen availability. Thus, even assuming a lower 246 
availability of calcium, this may not have been sufficient to compromise performance. 247 
Secondly, the release of calcium into the sarcoplasmic reticulum is not the only 248 
mechanism of action by which caffeine influences performance20. Given that there is 249 
debate in regard to the mechanism by which caffeine is ergogenic, the results of the 250 
current study would imply that increased caffeine availability in the sarcoplasmic 251 
reticulum might not be the prime mechanism by which caffeine ingestion enhances 252 
muscular performance. 253 
It has previously been established that caffeine can also act in the central 254 
nervous system by blocking adenosine receptors21, attenuating the action of adenosine 255 
and increasing the release of adrenergic neurotransmitters to reduce PP22. In the 256 
context of the current study, this may have helped individuals to continue performing 257 
the exercise for a longer duration and, consequently, increasing the number of 258 
repetitions performed with a concomitant increase in blood lactate values post 259 
exercise. The observed increase in blood lactate might also be associated with 260 
increased PP. However, in the present study, PP was lower in the caffeine condition 261 
(with large Cohen’s d ES) throughout the sets. In addition, lactate appears to influence 262 
PP depending on the concentration of protons and ATP24. Thus, high lactate values 263 
may not increase PP. This finding aligns with other studies that have also reported 264 
dampened PP during resistance exercise with caffeine ingestion11. Conversely, no 265 
significant differences in RPE were identified as a consequence of the substance 266 
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ingested. Such a finding is congruent with other resistance exercise data, where the 267 
authors hypothesized that caffeine may be able to improve performance by maintaining 268 
similar levels of perceived exertion to those who produced less work23.  269 
Concerning the number of repetitions during exercise with BFR, there was 270 
a significant difference between CAF and PLA until the 2nd set (P<0.05 and large 271 
Cohen’s d ES). The non-significant difference in the 3rd set may be associated with 272 
fatigue in both groups. In this context, the ergogenic effect of caffeine may not be 273 
realized when several sets are performed to exhaustion and could be indicative that 274 
caffeine enhances peak strength performance.  It is important to note that there was a 275 
significant difference in repetitions between subjects who correctly identified caffeine 276 
intake and those who did not identify the intake of caffeine. Some studies have carried 277 
out an individual analysis on the effects of caffeine on performance and identified that 278 
some subjects did not present an ergogenic effect25. In other studies, the authors 279 
analyzed the side effects of caffeine action to see if the sample could identify the 280 
substance ingested26. In the present study, we did not perform individual performance 281 
analysis and also did not verify side effects - we only asked the subjects at the end of 282 
the experiment if they thought that caffeine had been the first or second capsule 283 
consumed. It is important to reinforce that, irrespective of whether subjects correctly 284 
identified the caffeine ingestion trial or not, the participants performed more repetitions 285 
when they ingested caffeine compared to when placebo was ingested. However, 286 
subjects who correctly identified caffeine performed more repetitions than those who 287 
did not. Our results agree with the study by Saunders et al.27 The authors found that 288 
cyclists who correctly identified caffeine improved cycling performance to a greater 289 
extent than the overall effect of caffeine; and the performance also improved when 290 
participants ingested caffeine while believed they were ingesting placebo. Therefore, 291 
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the results of this study reinforces the possibility that caffeine has an individualized 292 
physiological and psychological action, allowing some subjects to have a superior 293 
ergogenic effect to others as a consequence of their expectancy of the effect of the 294 
substance they have ingested. 295 
In regard to blood lactate responses to exercise, we observed an increase 296 
in this variable after exercise in both the placebo and caffeine conditions. Studies have 297 
shown that resistance exercise with BFR may result in blood lactate concentration 298 
values similar5 or higher28 when compared to high intensity exercise without BRF. It is 299 
worth mentioning that this type of exercise has some peculiarities in relation to 300 
conventional training of moderate-high intensity, among them is maintaining the blood 301 
flow restriction even in the recovery periods, which can significantly decrease the 302 
removal of blood lactate in the target muscles6. 303 
However, in the current study, blood lactate was higher after the exercise 304 
performed with caffeine intake. Such a finding is congruent with recent meta-analytical 305 
data identifying that acute caffeine intake significantly increases plasma lactate29. In 306 
the present study, a possible explanation the greater number of repetitions performed 307 
after caffeine ingestion, would have also been associated with a longer duration of 308 
effort and a longer time in the BFR condition. As a consequence of this, blood lactate 309 
may have been elevated simply because of the greater work performed in the caffeine 310 
condition rather than because of the caffeine ingested. Despite this potential 311 
explanation, some studies have shown that plasma lactate did not change after 312 
caffeine intake even with increased performance30. In this sense, the effect of caffeine 313 
on plasma lactate is still inconclusive and requires further investigation. 314 
 315 
PRACTICAL APPLICATIONS 316 
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The present study is the first to investigate the acute effects of caffeine on 317 
an exercise performed with BFR. The positive effect of acute caffeine intake to increase 318 
the number of repetitions during unilateral knee extension with BFR may help 319 
practitioners, athletes and coaches to optimize the performance in this model of 320 
resistance exercise. Notwithstanding, regardless of the results presented, there are 321 
some limitations of the current study. We used a single unilateral lower limb exercise 322 
as our outcome measure of resistance exercise performance. The results of the 323 
present study are only reflective of this type of exercise and we cannot confirm that the 324 
results presented herein would be reproducible in bilateral exercises and/or with 325 
different muscle mass. Plasma caffeine concentration was not measured and thus we 326 
cannot confirm the bioavailability of this substance in all study subjects. We did not test 327 
the reliability of the measurements during the exercises protocols. Although our 328 
subjects were familiar with resistance exercise protocols, they were not regular 329 
practitioners of resistance exercise with BFR. Exercise with BFR may feel different to 330 
exercise without BFR and as such some of the observed changes might be attributable 331 
to the feeling of the exercise, the error of measurement or to learning effects. Finally, 332 
as this is an acute study, we cannot verify whether the greater number of repetitions 333 
performed after caffeine intake would be significant to promote a superior effect on 334 
strength or muscle mass when analyzed in the long term. Future research would be 335 
welcome examines these issues and also seeks to replicate the results of the current 336 
study. 337 
 338 
CONCLUSION 339 
Acute caffeine supplementation increases physical performance and 340 
decreases PP in an exercise session of unilateral knee extension with BFR.  341 
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Table 1. General characteristics of the sample (n=22). 444 
Age (years) 23.4 ± 4.1 
Height (cm) 177.2 ± 3.9 
Weight (kg) 76.7 ± 4.0 
Time of training (years) 2.6 ± 1.1 
Level of BFR during exercise (mmHg) 131.4 ± 14.6 
Habitual caffeine consumption (mg.day-1) 80.1 ± 10.4 
1 RM (kg) 87.2 ± 61.1 
30% of 1 RM (kg) 26.2 ± 2.5 
 445 
  446 
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Table 2. Results of the two-way ANOVA with repeated measures to effect of caffeine supplementation on the number of repetitions, 447 
rating of perceived exertion and pain perceived. 448 
 Caffeine Placebo Inter-group P 
value (caffeine vs 
placebo) 
Cohen’s d effect 
size 
Cohen’ d 
classification 
Repetitions      
1st set 28.3 ± 5.3* 23.7 ± 3.2* 0.005 1.05 Large 
2nd set 11.6 ± 3.1† 8.9 ± 2.9† 0.03 0.90 Large 
3rd set 4.6 ± 3.6 2.4 ± 3.0 NS 0.66 Medium 
Total 44.5 ± 9.4 35.0 ± 6.6 0.001 1.17 Large 
Rating of 
perceived exertion 
     
1st set 6.3 ± 1.5* 6.1 ± 1.9* NS 0.11 Small 
20 
 
2nd set 8.4 ± 1.1 8.5 ± 1.5 NS 0.07 Small 
3rd set 9.4 ± 0.3 9.6 ± 0.8 NS 0.33 Small 
Pain perceived      
1st set 5.2 ± 1.0* 5.9 ± 2.2* NS 0.40 Small 
2nd set 6.9 ± 1.5† 8.4 ± 1.4 0.04 1.03 Large 
3rd set 8.7 ± 0.4 9.5 ± 0.6 0.01 1.57 Large 
* Intra-groups significant difference (P=0.02) from 1st and 2nd sets; † Intra-groups significant difference (P=0.04) from 3rd set; NS = 449 
non-significant difference 450 
 451 
  452 
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Table 3. Results of the two-way ANOVA to the total number of repetitions performed between subjects who scored correctly and 453 
those who made a mistake about caffeine intake. 454 
 Caffeine Placebo Inter-group P value 
(caffeine vs placebo) 
Cohen’s d 
effect size 
Cohen’s d 
classification 
Correct identification of  
caffeine (n=9) 
48.8±4.8 35.7±7.7 0.002 2.04 Large 
Non-correct identification of 
caffeine (n=13) 
41.5±7.1 34.5±6.0 0.001 1.06 Large 
Intra-groups P value (correct vs 
non-correct) 
0.04 NS - - - 
NS = non-significant difference 455 
 456 
  457 
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Figure 1. Individual responses between caffeine and placebo sessions 460 
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